NDS Notice Board

---

NDS Notice Board

• January 9, 2020

  NDSAC Meeting of March 8-9, 2020

  The proposed meeting of the National Drug Scheduling Advisory Committee (NDSAC) for March 8-9, 2020 is cancelle

• December 9, 2019

  NDSAC Interim Recommendations on fluticasone propionate nasal spray

  A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on December 1, 2

• November 29, 2019

  NAPRA updates its Policy on Natural Health Products

  NAPRA is updating its policy on and approach to Natural Health Products (NHPs) in NAPRA’s National Drug Schedules with the best interest of the public as its first and foremost concern.

• October 3, 2019

  National Drug Scheduling Advisory Committee Meeting December 1, 2019

  The next meeting of the National Drug Scheduling Advisory Committ

• July 17, 2019

  2020 Meeting Schedule for the National Drug Scheduling Advisory Committee (NDSAC)

  The following are the tentative meeting dates for the National Drug Scheduling Advisory Committee (NDSAC) in 2020.

• July 11, 2019

  NDSAC Meeting of September 8-9, 2019 is cancelled
• November 13, 2018

  National Drug Schedules: Final Recommendations for esomeprazole 20 mg

  The interim recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on October 11, 2018 that:

• October 11, 2018

  NDSAC Interim Recommendations regarding esomeprazole 20 mg

  A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held via electronic participation from October 4-10, 2018 with the following interim recommendations made:

• September 17, 2018

  NDSAC meeting of September 9, 2018

  A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on September 9, 2018 to consider the following matters:

• March 8, 2018

  National Drug Schedules: Revisions to By-law No. 2

  The National Association of Pharmacy Regulatory Authorities recently underwent a change in governance. Subsequent to this change in governance, small changes were required to By-law No. 2, which sets out the framework for the operation of the National Drug Schedules (NDS) program.